Literature DB >> 10349992

Monoclonal antibody-based immunohistochemical diagnosis of rickettsialpox: the macrophage is the principal target.

D H Walker1, S D Hudnall, W K Szaniawski, H M Feng.   

Abstract

Cutaneous biopsies of five eschars and two rash lesions from five patients from New York City with documented rickettsialpox were examined by immunohistochemical methods with a monoclonal antibody directed against spotted fever group rickettsial lipopolysaccharide for the presence and cellular location of Rickettsia akari Rickettsiae were identified in all of the five patients, with good concordance of results for the same biopsy tissues with previously reported results by the direct immunofluorescence method. In contrast with immunofluorescence, which did not reveal the location of the organisms, immunohistochemical examination demonstrated R. akari to be in perivascular cells, morphologically resembling macrophages. Evaluation with double staining for rickettsiae and either CD68 or Factor VIII-related antigen revealed that the predominant infected cell type was CD68-positive macrophages, and only a rare rickettsia was detected in vascular endothelium, the major target cell for other rickettsioses. These results provide a diagnostic method for rickettsialpox and other spotted fever group rickettsioses and indicate that the elucidation of the pathogenesis of rickettsialpox must take into account that its target cell differs from that of Rocky Mountain spotted fever, boutonneuse fever, louse-borne typhus fever, and murine typhus.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10349992

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  20 in total

Review 1.  The role of CD8 T lymphocytes in rickettsial infections.

Authors:  David H Walker; J Stephen Dumler
Journal:  Semin Immunopathol       Date:  2015-04-01       Impact factor: 9.623

2.  Persisting Rickettsia typhi Causes Fatal Central Nervous System Inflammation.

Authors:  Anke Osterloh; Stefanie Papp; Kristin Moderzynski; Svenja Kuehl; Ulricke Richardt; Bernhard Fleischer
Journal:  Infect Immun       Date:  2016-04-22       Impact factor: 3.441

3.  Activation of ASC Inflammasome Driven by Toll-Like Receptor 4 Contributes to Host Immunity against Rickettsial Infection.

Authors:  Claire Rumfield; Ilirjana Hyseni; Jere W McBride; David H Walker; Rong Fang
Journal:  Infect Immun       Date:  2020-03-23       Impact factor: 3.441

4.  Rickettsia-macrophage interactions: host cell responses to Rickettsia akari and Rickettsia typhi.

Authors:  S Radulovic; P W Price; M S Beier; J Gaywee; J A Macaluso; A Azad
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

Review 5.  Pathogenesis of Rickettsial Diseases: Pathogenic and Immune Mechanisms of an Endotheliotropic Infection.

Authors:  Abha Sahni; Rong Fang; Sanjeev K Sahni; David H Walker
Journal:  Annu Rev Pathol       Date:  2018-08-27       Impact factor: 23.472

6.  Recent research milestones in the pathogenesis of human rickettsioses and opportunities ahead.

Authors:  Hema P Narra; Abha Sahni; David H Walker; Sanjeev K Sahni
Journal:  Future Microbiol       Date:  2020-07-21       Impact factor: 3.165

Review 7.  Host-cell interactions with pathogenic Rickettsia species.

Authors:  Sanjeev K Sahni; Elena Rydkina
Journal:  Future Microbiol       Date:  2009-04       Impact factor: 3.165

8.  Fc-dependent polyclonal antibodies and antibodies to outer membrane proteins A and B, but not to lipopolysaccharide, protect SCID mice against fatal Rickettsia conorii infection.

Authors:  Hui-Min Feng; Ted Whitworth; Juan P Olano; Vsevolod L Popov; David H Walker
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

9.  Tropism and pathogenicity of rickettsiae.

Authors:  Tsuneo Uchiyama
Journal:  Front Microbiol       Date:  2012-06-25       Impact factor: 5.640

10.  Fatal spotted fever rickettsiosis, Minas Gerais, Brazil.

Authors:  Márcio Antonio Moreira Galvâo; J Stephen Dumler; Cláudio Lísias Mafra; Simone Berger Calic; Chequer Buffe Chamone; Gracco Cesarino Filho; Juan Pablo Olano; David H Walker
Journal:  Emerg Infect Dis       Date:  2003-11       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.